[go: up one dir, main page]

TR201009396A2 - Desloratadin granüller - Google Patents

Desloratadin granüller

Info

Publication number
TR201009396A2
TR201009396A2 TR2010/09396A TR201009396A TR201009396A2 TR 201009396 A2 TR201009396 A2 TR 201009396A2 TR 2010/09396 A TR2010/09396 A TR 2010/09396A TR 201009396 A TR201009396 A TR 201009396A TR 201009396 A2 TR201009396 A2 TR 201009396A2
Authority
TR
Turkey
Prior art keywords
desloratadine
granules
polymorph
enantiomer
solvate
Prior art date
Application number
TR2010/09396A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/09396A priority Critical patent/TR201009396A2/tr
Priority to PCT/TR2011/000242 priority patent/WO2012064300A2/en
Publication of TR201009396A2 publication Critical patent/TR201009396A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, desloratadin veya farmasötik olarak kabul edilebilir bir tuzu, solvatı, türevi, polimorfu, hidratı veya enantiyomerinin terapötik olarak etkili bir miktarını içeren granüller ve bunların üretim yöntemi ile ilgilidir.
TR2010/09396A 2010-11-11 2010-11-11 Desloratadin granüller TR201009396A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/09396A TR201009396A2 (tr) 2010-11-11 2010-11-11 Desloratadin granüller
PCT/TR2011/000242 WO2012064300A2 (en) 2010-11-11 2011-11-03 Desloratadine granules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/09396A TR201009396A2 (tr) 2010-11-11 2010-11-11 Desloratadin granüller

Publications (1)

Publication Number Publication Date
TR201009396A2 true TR201009396A2 (tr) 2012-05-21

Family

ID=45491748

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/09396A TR201009396A2 (tr) 2010-11-11 2010-11-11 Desloratadin granüller

Country Status (2)

Country Link
TR (1) TR201009396A2 (tr)
WO (1) WO2012064300A2 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016140630A1 (en) * 2015-03-05 2016-09-09 PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. An effervescent composition comprising levocetirizine and pseudoephedrine
CN111398505B (zh) * 2020-04-28 2022-04-08 健民药业集团股份有限公司 同时检测一种治疗小儿遗尿症中药的五种成分含量的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570306B2 (en) 1984-02-15 1988-03-10 Schering Corporation 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts.
PE71699A1 (es) 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
SK287684B6 (sk) 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
US20070014855A1 (en) 2005-07-12 2007-01-18 Rahul Gawande S Stable desloratadine compositions
US20070048373A1 (en) * 2005-08-30 2007-03-01 Cima Labs Inc. Dried milled granulate and methods
CA2541045A1 (en) * 2006-03-24 2007-09-24 Pharmascience Inc. A descarbonylethoxyloratadine containing pharmaceutical composition
EA024112B1 (ru) * 2008-11-28 2016-08-31 КРКА, д.д., НОВО МЕСТО Твердая фармацевтическая композиция дезлоратадина, содержащая стабилизирующий агент

Also Published As

Publication number Publication date
WO2012064300A3 (en) 2012-08-02
WO2012064300A2 (en) 2012-05-18

Similar Documents

Publication Publication Date Title
NL301201I2 (nl) Asciminib of een farmaceutisch aanvaardbaar zout daarvan, zoals asciminibhydrochloride
NL301191I2 (nl) voxelotor of een tautomeer of farmaceutisch aanvaardbaar zout daarvan
NL301294I2 (nl) Dasiglucagon of een farmaceutisch aanvaardbaar zout of solvaat daarvan, zoals dasiglucagon hydrochloride
NO2023040I1 (no) Atogepant or a pharmaceutically acceptable salt thereof
NL301157I2 (nl) odevixibat of een farmaceutisch aanvaardbaar zout daarvan
LTPA2017039I1 (lt) Pirolopirimidino junginiai, kaip CDK inhibitoriai
NL300901I2 (nl) pibrentasvir of een farmaceutisch aanvaardbaar zout daarvan
EP2566477A4 (en) AMINO-QUINOLINES AS KINASE INHIBITORS
PH12014502733A1 (en) Neprilysin inhibitors
HUE037154T2 (hu) Szubsztituált benzilindazol-származékok mint Bub1 kinázgátlók hiperproliferatív megbetegedések kezelésére
IL237582A0 (en) Cdk inhibitors
EP2729806A4 (en) USE OF MARKED HSP90 INHIBITORS
PH12014500883A1 (en) Uracil derivatives as axl and c-met kinase inhibitors
BR302013000237S1 (pt) "configuração aplicada em fone de ouvido"
ZA201300533B (en) Pharmaceutically active compounds as axl inhibitors
HUE056588T2 (hu) Eljárás poliolefinek elõállítására
EA201490161A1 (ru) Соединения - ингибиторы сигналинга, опосредуемого рецептором notch
EA201590520A1 (ru) Фармацевтическая композиция с покрытием, содержащая регорафениб
EP2863748A4 (en) 1,2,4-triazine-6-CARBOXAMIDKINASEINHIBITOREN
EP2740478A4 (en) PREPARATION FOR MAINTAINED RELEASE OF IVABRADINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
IL223131A0 (en) Heterocyclic compounds as janus kinase inhibitors
EP2648519A4 (en) NEW POLYMORPH OF NILOTINIB HYDROCHLORIDE
IT1402824B1 (it) Pacchetto di sigarette.
UA111475C2 (uk) Способи лікування із застосуванням ліпідних сполук
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения